Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Hyperaldosteronism
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
The unregulated release of excess aldosterone from one or both adrenal glands == '''Epidemiology''' == * Believed to affect about 1-7% of patients with HTN * Mean age at diagnosis 50yo * Slight male predilection == '''Aetiology''' == * Primary hyperaldosteronism: ** Autonomous overproduction of aldosterone by the adrenal glands, and not suppressed by sodium loading. *** Unilateral aldosterone-producing adenomas (most common) *** Bilateral adrenal hyperplasia (aka 'idiopathic hyperaldosteronism') *** Familial hyperaldosteronism == '''Presentation''' == * HTN - often moderate-to-severe that is refractory to medical therapy ** Responsiveness to spironolactone is a good prognostic factor for surgery * Most patients are otherwise asymptomatic ** Hypokalaemia (found in less than 40% of patients with primary aldosteronism - likely severe or late-stage disease) ** Can be a/w cardiovascular disease, including LVH, AF, MI, CVA *** These may regress with cure ** Classically, Conn's syndrome - HTN, polyuria-polydipsia, and hypokalaemia == '''Workup indications:''' == * HTN and spontaneous, or low-dose diuretic-induced, hypokalaemia * Severe HTN or drug-resistant HTN (on three-drug program including adrenergic inhibitor, vasodilator and diuretic) * HTN with adrenal incidentaloma * HTN with OSA * HTN and family history of early-onset HTN or CVA<40yo * HTN and first-degree relative of patient with primary hyperaldosteronism * HTN and AF == '''Workup:''' == * '''Initial testing:''' ** Establish ratio of plasma aldosterone to renin *** Discontinue spironolactone, ACE inhibitors, diuretics and beta-blockers beforehand *** Common normal range cut-off of >30:1 gives a sensitivity of 90%. Using a cut-off of >20:1 instead increases sensitivity at cost of specificity; this reflects appreciation of the clinical gravity of missing surgically correctable hyperaldosteronism. *** Also good to require absolute aldosterone concentration >15mg/dL, since otherwise some patients with fairly normal aldosterone but low renin would meet criteria *** Plasma renin activity or plasma renin concentration reduced (typically undetectable) *** Plasma aldosterone concentration is inappropriately high for renin * '''Confirmatory testing:''' ** Confirm that high aldosterone levels are non-suppressible with either IV sodium loading (2-3L of isotonic saline over 4-6 hours, followed by measurement of plasma aldosterone) or oral salt loading (5g sodium daily for three days, followed by measurement of 24-hour aldosterone excretion) * '''Localisation''' ** CT - differentiate between adrenal hyperplasia and adenoma *** Adenomas are typically <2cm, aldosterone-producing carcinomas are almost always >4cm *** Thin-cut (3mm) adrenal CT ** Adrenal vein sampling *** Indications **** Strong indication: Normal CT or bilateral abnormalities **** Weak indication: When there is a higher chance that the identified lesion is a unilateral non-functioning cortical adenoma, and you may be missing a contralateral micro-aldosteronoma or bilateral adrenal hyperplasia ***** Some say patients >40yo with primary hyperaldosteronism ***** Some say all patients with primary hyperaldosteronism *** Simultaneous measurement of cortisol and aldosterone levels in the peripheral circulation and left and right adrenal veins *** Lateralisation is indicated by a four-fold ratio between sides * '''Genetic screening''' for patients that test positive at <30yo for familial hyperaldosteronism type I, especially if they have a family history of early-onset HTN == '''Surgery''' == * Indications ** Unilateral disease, either adenoma or hyperplasia, which is causing primary aldosteronism * Approach ** See separate topic under 'operations' * Cure metrics ** Complete - normal BP (less likely in patients that have underlying essential HTN) ** Partial - decrease in antihypertensive medication ** Absent * Post-op ** Stop all antihypertensive medications immediately post-op, with the exception of beta-blockers and clonidine to avoid rebound. Add back in as needed. ** Hyperaldosteronism can mask the true degree of CKD due to glomerular hyperfiltration ** Hyperkalaemia, related to renal function, occurs 1-3 weeks post-op - monitor with weekly UEC. Persistent hyperkalaemia can be treated with mineralocorticoid replacement (fludrocortisone). == '''Medical treatment''' == * Those unfit for surgery can be treated with mineralocorticoid receptor antagonists (spironolactone or eplerenone) [[Category:Endocrine]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Hyperaldosteronism
Add topic